Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Published ·
Keep reading
Published ·
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Keep reading